Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Jeffrey A. Potts

Internal Medicine
Total Family Healthcare P.C.
1111 S Euclid Ave, 
Bay City, MI 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients

Experienced in WT1-Related Wilms Tumor Syndromes
Total Family Healthcare P.C.
1111 S Euclid Ave, 
Bay City, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jeffrey Potts is a primary care provider, practicing in Internal Medicine in Bay City, Michigan. Dr. Potts is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Cirrhosis, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Osteotomy, and Endoscopy. Dr. Potts is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 20 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in MI
Hospital Affiliations
Mclaren Bay Region
Mymichigan Medical Center Midland
Covenant Medical Center
Ascension St Mary's Hospital
Scheurer Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Michigan Health
  • HMO
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Upper Peninsula Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 22 Less Insurance Carriers -

Locations

TOTAL FAMILY HEALTHCARE P.C.
1111 S Euclid Ave, Bay City, MI 48706
Call: 989-439-1235
Other Locations
946 Midland Rd, Auburn, MI 48611
Call: 989-266-3266

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


17 Clinical Trials

A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain
An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drugs: Qutenza (Capsaicin) 8% Topical System, Capsaicin 0.04% Topical System
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: July 17, 2024
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
Phase 2/3 Study of Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease
Phase 2/3 Study of Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease
Enrollment Status: Terminated
Publish Date: June 06, 2024
Intervention Type: Drug
Study Drug: Upamostat
Study Phase: Phase 2/Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 30, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized Placebo-controlled Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Chronic Low Back Pain
Randomized Placebo-controlled Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: October 05, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 15 Less Clinical Trials

3 Total Publications

Augmented Reality Navigation in Craniomaxillofacial/Head and Neck Surgery.
Augmented Reality Navigation in Craniomaxillofacial/Head and Neck Surgery.
Journal: OTO open
Published: February 14, 2025
View All 3 Publications
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Naveed Mahfooz
Family Medicine | Internal Medicine
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Naveed Mahfooz
Family Medicine | Internal Medicine

Columbiaville Family Clinic PLLC

2575 Mcleod Dr N, Suite A, 
Saginaw, MI 
 (8.2 miles away)
989-797-5532
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Naveed Mahfooz is a primary care provider, practicing in Family Medicine and Internal Medicine in Saginaw, Michigan. Dr. Mahfooz is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Necrosis, Endoscopy, and Gastrostomy. Dr. Mahfooz is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Myroslav Harhula
Internal Medicine
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Myroslav Harhula
Internal Medicine

Mclaren Lapeer Region

1375 N Main St, 
Lapeer, MI 
 (47.1 miles away)
810-667-5677
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Myroslav Harhula is a primary care provider, practicing in Internal Medicine in Lapeer, Michigan. Dr. Harhula is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Sepsis, Acute Kidney Failure, Lung Metastases, Endoscopy, and Colonoscopy. Dr. Harhula is currently accepting new patients.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Revan N. Maragiri
Internal Medicine
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Revan N. Maragiri
Internal Medicine
1005 Mulholland St, 
Bay City, MI 
 (2.4 miles away)
989-391-9223
Languages Spoken:
English, Hindi, Kannada
See accepted insurances
Accepting New Patients
Offers Telehealth

Revan Maragiri is a primary care provider, practicing in Internal Medicine in Bay City, Michigan. Dr. Maragiri is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Pneumonia, Lung Metastases, Atherosclerosis, Ureteroscopy, and Vertebroplasty. Dr. Maragiri is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Potts's expertise for a condition
ConditionClose
    • Distinguished
    • Cirrhosis
      Dr. Potts is
      Distinguished
      . Learn about Cirrhosis.
      See more Cirrhosis experts
    • COVID-19
      Dr. Potts is
      Distinguished
      . Learn about COVID-19.
      See more COVID-19 experts
    • Familial Combined Hyperlipidemia
      Dr. Potts is
      Distinguished
      . Learn about Familial Combined Hyperlipidemia.
      See more Familial Combined Hyperlipidemia experts
    • Familial Hypertension
      Dr. Potts is
      Distinguished
      . Learn about Familial Hypertension.
      See more Familial Hypertension experts
    • Generalized Anxiety Disorder (GAD)
      Dr. Potts is
      Distinguished
      . Learn about Generalized Anxiety Disorder (GAD).
      See more Generalized Anxiety Disorder (GAD) experts
    • Glucocorticoid-Remediable Aldosteronism
      Dr. Potts is
      Distinguished
      . Learn about Glucocorticoid-Remediable Aldosteronism.
      See more Glucocorticoid-Remediable Aldosteronism experts
    View All 16 Distinguished Conditions
    • Advanced
    • Acne
      Dr. Potts is
      Advanced
      . Learn about Acne.
      See more Acne experts
    • Acute Cystitis
      Dr. Potts is
      Advanced
      . Learn about Acute Cystitis.
      See more Acute Cystitis experts
    • Allergic Rhinitis
      Dr. Potts is
      Advanced
      . Learn about Allergic Rhinitis.
      See more Allergic Rhinitis experts
    • Alopecia Areata
      Dr. Potts is
      Advanced
      . Learn about Alopecia Areata.
      See more Alopecia Areata experts
    • Anemia
      Dr. Potts is
      Advanced
      . Learn about Anemia.
      See more Anemia experts
    • Asthma
      Dr. Potts is
      Advanced
      . Learn about Asthma.
      See more Asthma experts
    View All 105 Advanced Conditions
    • Experienced
    • Accessory Pancreas
      Dr. Potts is
      Experienced
      . Learn about Accessory Pancreas.
      See more Accessory Pancreas experts
    • Acrogeria, Gottron Type
      Dr. Potts is
      Experienced
      . Learn about Acrogeria, Gottron Type.
      See more Acrogeria, Gottron Type experts
    • Acrospiroma
      Dr. Potts is
      Experienced
      . Learn about Acrospiroma.
      See more Acrospiroma experts
    • Acute Kidney Failure
      Dr. Potts is
      Experienced
      . Learn about Acute Kidney Failure.
      See more Acute Kidney Failure experts
    • Acute Mountain Sickness
      Dr. Potts is
      Experienced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Pancreatitis
      Dr. Potts is
      Experienced
      . Learn about Acute Pancreatitis.
      See more Acute Pancreatitis experts
    View All 424 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved